Candida E. Morley
Net worth: 128 355 $ as of 2026-08-30
Net worth: 128 355 $ as of 2026-08-30
Candida Morley has a Law Degree from Oxford and a Masters Degree in Small Business, together with extensive experience in investment banking / M&A (with Barings), venture capital (at 3i) and corporate development within a large plc (Harrisons & Crosfield).
She joined LDC in 2000.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-28 | 23,999 ( 0.01% ) | 128 355 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| PANTHEON INTERNATIONAL PLC | Director/Board Member | 2025-01-30 |
| Companies | Position | End |
|---|---|---|
Lloyds Development Capital (Holdings) Ltd.
Lloyds Development Capital (Holdings) Ltd. Investment ManagersFinance LDC invests in mid-market companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for MBOs, secondary buyout, buy & build and development capital requirements with a minimum investment size of GBP 100 million. It acquires minority and majority stakes and makes follow on investments. | Private Equity Investor | 2014-12-31 |
Penn Pharmaceutical Services Ltd.
Penn Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development, clinical trial supply and manufacturing services | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Pantheon International Plc
Pantheon International Plc Investment ManagersFinance Acts as Private Equity Fund | Finance |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lloyds Development Capital (Holdings) Ltd.
Lloyds Development Capital (Holdings) Ltd. Investment ManagersFinance LDC invests in mid-market companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for MBOs, secondary buyout, buy & build and development capital requirements with a minimum investment size of GBP 100 million. It acquires minority and majority stakes and makes follow on investments. | Finance |
Penn Pharmaceutical Services Ltd.
Penn Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development, clinical trial supply and manufacturing services | Health Technology |
Select your edition
All financial news and data tailored to specific country editions